Re:2,000% price hike for infant seizure drug called 'absurd'
by vonmoltke on Tuesday November 17, 2015 @10:51AM
(#10581831)
"Motivation" in the business sense of "can make sufficient return on investment", not the trivially reductionist sense of "I feel like making a new drug today". So regulatory costs affect the motivation.
[ Parent
| on HN ]
There are no comments on this comment yet.